Ben Boursi1, Ronac Mamtani2, Kevin Haynes2, Yu-Xiao Yang3. 1. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; The Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel; Tel-Aviv University, Tel-Aviv, Israel. 2. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 3. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: yangy@mail.med.upenn.edu.
Abstract
BACKGROUND: Bacterial dysbiosis was previously described in human malignancies. In a recent animal model, tumour susceptibility was transmitted using faecal transplantation. Our aim was to evaluate possible association between antibiotic exposure and cancer risk. METHODS: We conducted nested case-control studies for 15 common malignancies using a large population-based electronic medical record database. Cases were defined as those with any medical code for the specific malignancy. Individuals with familial cancer syndromes were excluded. For every case, four eligible controls matched on age, sex, practice site and duration of follow-up before index-date were selected using incidence-density sampling. Exposure of interest was antibiotic therapy >1 year before index-date. Adjusted odds-ratios (AORs) and 95% confidence intervals (CIs) were estimated for each antibiotic type using conditional logistic regression. RESULTS: 125,441 cases and 490,510 matched controls were analysed. For gastro-intestinal malignancies, the use of penicillin was associated with an elevated risk of oesophageal, gastric and pancreatic cancers. The association increased with the number of antibiotic courses and reached 1.4 for gastric cancers associated with >5 courses of penicillin (95% CI 1.2-1.8). Lung cancer risk increased with the use of penicillin, cephalosporins, or macrolides (AOR for >5 courses of penicillin: 1.4 95% CI 1.3-1.6). The risk of prostate cancer increased modestly with the use of penicillin, quinolones, sulphonamides and tetracyclines. The risk of breast cancer was modestly associated with exposure to sulphonamides. There was no association between the use of anti-virals and anti-fungals and cancer risk. CONCLUSION: Recurrent exposure to certain antibiotics may be associated with cancer risk in specific organ sites.
BACKGROUND: Bacterial dysbiosis was previously described in humanmalignancies. In a recent animal model, tumour susceptibility was transmitted using faecal transplantation. Our aim was to evaluate possible association between antibiotic exposure and cancer risk. METHODS: We conducted nested case-control studies for 15 common malignancies using a large population-based electronic medical record database. Cases were defined as those with any medical code for the specific malignancy. Individuals with familial cancer syndromes were excluded. For every case, four eligible controls matched on age, sex, practice site and duration of follow-up before index-date were selected using incidence-density sampling. Exposure of interest was antibiotic therapy >1 year before index-date. Adjusted odds-ratios (AORs) and 95% confidence intervals (CIs) were estimated for each antibiotic type using conditional logistic regression. RESULTS: 125,441 cases and 490,510 matched controls were analysed. For gastro-intestinal malignancies, the use of penicillin was associated with an elevated risk of oesophageal, gastric and pancreatic cancers. The association increased with the number of antibiotic courses and reached 1.4 for gastric cancers associated with >5 courses of penicillin (95% CI 1.2-1.8). Lung cancer risk increased with the use of penicillin, cephalosporins, or macrolides (AOR for >5 courses of penicillin: 1.4 95% CI 1.3-1.6). The risk of prostate cancer increased modestly with the use of penicillin, quinolones, sulphonamides and tetracyclines. The risk of breast cancer was modestly associated with exposure to sulphonamides. There was no association between the use of anti-virals and anti-fungals and cancer risk. CONCLUSION: Recurrent exposure to certain antibiotics may be associated with cancer risk in specific organ sites.
Authors: James J Farrell; Lei Zhang; Hui Zhou; David Chia; David Elashoff; David Akin; Bruce J Paster; Kaumudi Joshipura; David T W Wong Journal: Gut Date: 2011-10-12 Impact factor: 23.059
Authors: Hedvig E Jakobsson; Cecilia Jernberg; Anders F Andersson; Maria Sjölund-Karlsson; Janet K Jansson; Lars Engstrand Journal: PLoS One Date: 2010-03-24 Impact factor: 3.240
Authors: Siobhan Sutcliffe; Edward Giovannucci; William B Isaacs; Walter C Willett; Elizabeth A Platz Journal: Int J Cancer Date: 2007-12-15 Impact factor: 7.396
Authors: Kevin Haynes; Kimberly A Forde; Rita Schinnar; Patricia Wong; Brian L Strom; James D Lewis Journal: Pharmacoepidemiol Drug Saf Date: 2009-08 Impact factor: 2.890
Authors: Iradj Sobhani; Julien Tap; Françoise Roudot-Thoraval; Jean P Roperch; Sophie Letulle; Philippe Langella; Gérard Corthier; Jeanne Tran Van Nhieu; Jean P Furet Journal: PLoS One Date: 2011-01-27 Impact factor: 3.240
Authors: Balazs I Bodai; Therese E Nakata; William T Wong; Dawn R Clark; Steven Lawenda; Christine Tsou; Raymond Liu; Linda Shiue; Neil Cooper; Michael Rehbein; Benjamin P Ha; Anne Mckeirnan; Rajiv Misquitta; Pankaj Vij; Andrew Klonecke; Carmelo S Mejia; Emil Dionysian; Sean Hashmi; Michael Greger; Scott Stoll; Thomas M Campbell Journal: Perm J Date: 2018
Authors: Guang-Shing Cheng; Louise Bondeelle; Ted Gooley; Qianchuan He; Kareem Jamani; Elizabeth F Krakow; Mary E D Flowers; Régis Peffault de Latour; David Michonneau; Gérard Socié; Jason W Chien; Sylvie Chevret; Anne Bergeron Journal: Biol Blood Marrow Transplant Date: 2019-11-01 Impact factor: 5.742